Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Murray

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Pharmaceutical Statistics|March 19, 2021
Logistic retainment interval dose exploration design for Phase I clinical trials of cytotoxic agentsThomas A Murray
Biometrics|June 13, 2020
Batch Bayesian optimization design for optimizing a neurostimulatorAdam Kaplan, Thomas A Murray
Biometrics|April 8, 2022
An alternative metric for evaluating the potential patient benefit of response-adaptive randomization proceduresJennifer Proper, Thomas A Murray
Statistics in Medicine|October 18, 2024
Phase I/II Design for Selecting Subgroup-Specific Optimal Biological Doses for Prespecified SubgroupsSydney Porter, Thomas A Murray, Anne Eaton
Statistical Methods in Medical Research|April 1, 2025
Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilitiesSydney Porter, Anne Eaton, Thomas A Murray
Journal of the American Statistical Association|February 12, 2019
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment RegimesThomas A Murray, Ying Yuan, Peter F Thall
Statistics in Medicine|May 19, 2016
Utility-based designs for randomized comparative trials with categorical outcomesThomas A Murray, Peter F Thall, Ying Yuan
Statistics in Medicine|April 24, 2018
Comparative review of novel model-assisted designs for phase I clinical trialsHeng Zhou, Thomas A Murray, Haitao Pan, et al.
The Annals of Applied Statistics|November 12, 2015
COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORSThomas A Murray, Brian P Hobbs, Bradley P Carlin
Clinical Trials (London, England)|November 29, 2012
Bayesian adaptive design for device surveillanceThomas A Murray, Bradley P Carlin, Theodore C Lystig
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Pharmaceutical Statistics|March 19, 2021
Logistic retainment interval dose exploration design for Phase I clinical trials of cytotoxic agentsThomas A Murray
Biometrics|June 13, 2020
Batch Bayesian optimization design for optimizing a neurostimulatorAdam Kaplan, Thomas A Murray
Biometrics|April 8, 2022
An alternative metric for evaluating the potential patient benefit of response-adaptive randomization proceduresJennifer Proper, Thomas A Murray
Statistics in Medicine|October 18, 2024
Phase I/II Design for Selecting Subgroup-Specific Optimal Biological Doses for Prespecified SubgroupsSydney Porter, Thomas A Murray, Anne Eaton
Statistical Methods in Medical Research|April 1, 2025
Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilitiesSydney Porter, Anne Eaton, Thomas A Murray
Journal of the American Statistical Association|February 12, 2019
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment RegimesThomas A Murray, Ying Yuan, Peter F Thall
Statistics in Medicine|May 19, 2016
Utility-based designs for randomized comparative trials with categorical outcomesThomas A Murray, Peter F Thall, Ying Yuan
Statistics in Medicine|April 24, 2018
Comparative review of novel model-assisted designs for phase I clinical trialsHeng Zhou, Thomas A Murray, Haitao Pan, et al.
The Annals of Applied Statistics|November 12, 2015
COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORSThomas A Murray, Brian P Hobbs, Bradley P Carlin
Clinical Trials (London, England)|November 29, 2012
Bayesian adaptive design for device surveillanceThomas A Murray, Bradley P Carlin, Theodore C Lystig
Pageof 7